Day: December 13, 2019

CALGARY, Alberta, Dec. 13, 2019 (GLOBE NEWSWIRE) — Peyto Exploration & Development Corp. (TSX: PEY) (“Peyto”) confirms that the monthly dividend with respect to December 2019 of $0.02 per common share is to be paid on January 15, 2020, for shareholders of record on December 31, 2019.  The ex-dividend date is December 30, 2019.Dividends paid by Peyto to Canadian residents are eligible dividends for Canadian income tax purposes.Peyto has also finalized its 2020 budget and the Board of Directors has approved the $250-$300 million 2020 capital program as previously described in the third quarter 2019 press release. The capital program is expected to be funded entirely from free cashflow but Peyto will ensure it remains nimble with the ability to react to changing commodity prices and the global economic environment.Shareholders...

MONTREAL, Dec. 13, 2019 (GLOBE NEWSWIRE) — Midland Exploration Inc. (“Midland”) (TSX-V: MD) is pleased to announce that it has completed a second tranche of the non brokered private placement previously announced on December 4, 2019 (the “Offering”) by issuing a total of 63,638 flow-through common shares (the “Flow-Through Shares”) at $1.10 per share for gross proceeds of CAD $70,002 and by issuing a total of 73,791 of common share at $0.85 for gross proceeds of CAD $62,722. The total gross proceeds of the Offering to the Corporation is CAD $1,604,955. The securities issued in the second tranche of the Offering are subject to a four-month hold period expiring on April 14, 2020.BHP Billiton Canada Inc. (“BHP”) has exercised its right to maintain its ownership to 5.0% by acquiring 73,791 common shares of Midland. This right had been...

MONTRÉAL, 13 déc. 2019 (GLOBE NEWSWIRE) — Exploration Midland inc. (“Midland”) (TSX-V : MD) est heureuse d’annoncer la clôture d’une deuxième tranche du placement privé sans l’entremise d’un courtier antérieurement annoncé le 4 décembre 2019 (le « placement privé ») par l’émission de 63 638 actions ordinaires accréditives (les « actions accréditives ») à un prix de 1,10 $ chacune pour un produit brut de 70 002 $ et par l’émission de 73 791 actions ordinaires à un prix de $0.85 pour un produit brut de 62 722 $. Le total du produit brut du placement privé est de 1 604 955 $. Les titres émis dans le cadre de la deuxième tranche du placement privé sont soumis à une période de détention de quatre mois expirant le 14 avril 2020.BHP Billiton Canada Inc. (« BHP ») a exercé son droit de maintenir sa participation à 5,0% en acquérant...

MONTREAL, Dec. 13, 2019 (GLOBE NEWSWIRE) — Osisko Gold Royalties Ltd (TSX & NYSE:OR) (“Osisko”) announces that it has subscribed for and received from Osisko Metals Incorporated (TSXV:OM) (“Osisko Metals”), 14,000,000 units (the “Units”) of Osisko Metals for a price of $0.50 per Unit by way of a non-brokered private placement of Osisko Metals, for an aggregate subscription price of $7,000,000 (the “Transaction”).Each Unit is comprised of one (1) common share and one quarter (¼) of a share purchase warrant (each full warrant, a “Warrant”), each Warrant entitling the holder to purchase one (1) common share for a period of thirty-six (36) months from the closing date at a price of $0.52 per Warrant Share.Immediately prior to the closing of the Transaction, Osisko held, directly or indirectly, 15,877,397 common shares of Osisko...

MONTRÉAL, 13 déc. 2019 (GLOBE NEWSWIRE) — Redevances Aurifères Osisko Ltée (TSX et NYSE : OR) (« Osisko ») annonce qu’elle a souscrit à et a reçu de Osisko Metals Incorporated (TSXV : OM) (« Métaux Osisko ») 14 000 000 d’unités (les « unités ») de Métaux Osisko à un prix de 0,50 $ par unité au moyen d’un placement privé sans l’entremise d’un courtier de Métaux Osisko, pour un prix de souscription total de 7 000 000 $ (le « placement privé »).Chaque unité comprend une (1) action ordinaire de Métaux Osisko (l’ « action ») et le un quart d’un bon de souscription d’action ordinaire de Métaux Osisko (le « bon de souscription ») donnant le droit à son détenteur d’acquérir une (1) action ordinaire additionnelle de Métaux Osisko à un prix de 0,52 $ par action ordinaire pour une période de 36 mois suivant la date d’émission.Immédiatement...

NEW YORK, Dec. 13, 2019 (GLOBE NEWSWIRE) — iBio, Inc. (NYSE American: IBIO) (“iBio” or the “Company”), a leader in plant-based biologics manufacturing, announced today that on December 9, 2019, the Company received a letter from NYSE American LLC (“NYSE American” or the “Exchange”) indicating the Company’s securities have been selling for a low price per share for a substantial period of time and pursuant to Section 1003(f)(v) of the NYSE American Company Guide, the Company’s continued listing on the Exchange is predicated on the Company effecting a reverse stock split or otherwise demonstrating sustained improvement in its share price within a reasonable period of time, which the Exchange has determined to be no later than June 9, 2020.Additionally, the Company does not currently meet certain other NYSE American continued listing...

Vancouver, B.C., Dec. 13, 2019 (GLOBE NEWSWIRE) — Vancouver, BC, December 13, 2019 – INVICTUS MD STRATEGIES CORP. (“Invictus” or the “Company”) (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) announced today that Trevor Dixon has resigned from the Board of Directors of the Company effective immediately.  Marc Ripa has been appointed to the Board to fill the casual vacancy. Mr. Ripa stated, “On behalf of the Board, we wish to thank Trevor for his service as both a Director and Officer of the Company and as President and Director of the Company’s wholly owned subsidiary Acreage Pharms Ltd. We wish him all the best.” For more information, please visit www.invictus-md.com. Marc RipaChief Executive Officer Investor Relations 1-844-800-6086E-Mail: connect@invictus-md.com Neither the TSX Venture Exchange nor its Regulation...

VANCOUVER, British Columbia, Dec. 13, 2019 (GLOBE NEWSWIRE) — Westhaven Ventures Inc. (TSX-V:WHN) is pleased to announce the results of the Company’s Annual General meeting of Shareholders (“Meeting”) held in Vancouver, British Columbia on December 13, 2019. The shareholders approved all motions put forth at the Meeting including the re-appointment of Smythe LLP, Chartered Accountants, as the Company’s independent auditors, and the confirmation of the Company’s Stock Option Plan.The shareholders re-elected David Grenville Thomas, Gareth Thomas, Victor Tanaka, Hannah McDonald and Shaun Pollard to the Company’s Board of Directors.On behalf of the Board of DirectorsWESTHAVEN VENTURES INC. “Shaun Pollard”Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRES OR FOR DISSEMINATION IN THE UNITED STATESFRANKLIN, Ind., Dec. 13, 2019 (GLOBE NEWSWIRE) — IBC Advanced Alloys Corp. (“IBC” or the “Company”) (TSX-V: IB; OTCQB: IAALF) is pleased to announce that it has closed the Company’s previously announced non-brokered private placement (the “Offering”).

VASCEPA becomes the first and only FDA-approved medication for reducing cardiovascular risk beyond cholesterol lowering therapy in high-risk patients approved for treatmentMillions of people in the United States qualify as treatment candidates for VASCEPACardiovascular disease events, including heart attack, stroke and cardiovascular death, occur in the United States every 14 seconds and are economically, physically and emotionally costly VASCEPA has been assessed by independent bodies as priced cost effectively as a cardiovascular risk reduction treatment VASCEPA total net revenue guidance increased for 2019 to a range of $410 to $425 million and for 2020 is newly guided to a projected range of $650 to$700 millionAmarin to host webcast on Monday, December 16 at 7:30 a.m., Eastern TimeDUBLIN, Ireland and BRIDGEWATER, N.J., Dec. 13, 2019...